Cash flow Apollo Hospitals Enterprise Limited

Stocks

APOLLOHOSP

INE437A01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 12:05:07 17/07/2026 BST			5-day change	1st Jan Change
8,826.00 ^INR	-0.70%		-0.22%	+25.32%

07-03	Zydus Signs MoU with Apollo Hospitals to Offer Guardant Health?s Shield Multi-Cancer Detection Test in India	CI
07-03	Zydus Lifesciences Signs MoU With Apollo Hospitals for Multi-Cancer Detection Test; Shares Up 3%	MT

0bbb64.ZfSL2YZPlfuHwlv0TUQwVXWl0bVrMMcPgQYR-q4ZuUM.PLzEgMIX7b3KkxPEHnx2NiPvhvtdaJd5wHNhtYNB8QojpOWBzSjGr7T2bw

Published financial data: APOLLO HOSPITALS ENTERPRISE LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	106B	147B	166B	191B	218B
Total Revenues	106B	147B	166B	191B	218B
Cost of Goods Sold, Total	74.2B	95.32B	109B	125B	144B
Gross Profit	31.4B	51.31B	57.01B	65.69B	73.5B
Selling General & Admin Expenses, Total	2.64B	4.67B	7.83B	8.1B	7.18B
Provision for Bad Debts	-	-	-	-	-
Stock-Based Compensation (IS)	-	-	-	-	-
Depreciation & Amortization - (IS)	5.73B	6.01B	6.15B	6.87B	7.58B
Other Operating Expenses	17.36B	24.75B	28.53B	33.65B	35.98B
Other Operating Expenses, Total	25.72B	35.42B	42.52B	48.62B	50.74B
Operating Income	5.67B	15.88B	14.49B	17.07B	22.76B
Interest Expense, Total	-4.06B	-3.3B	-3.14B	-3.52B	-4.22B
Interest And Investment Income	218M	351M	444M	429M	930M
Net Interest Expenses	-3.84B	-2.95B	-2.69B	-3.1B	-3.3B
Income (Loss) On Equity Invest.	8M	73M	-432M	180M	330M
Currency Exchange Gains (Loss)	-41M	6M	3M	-	-
Other Non Operating Income (Expenses)	-205M	-321M	-500M	-729M	-135M
EBT, Excl. Unusual Items	1.59B	12.69B	10.87B	13.43B	19.66B
Gain (Loss) On Sale Of Investments	44M	264M	285M	374M	774M
Gain (Loss) On Sale Of Assets	-29M	-40M	-150M	-36M	-63M
Other Unusual Items	606M	2.94B	-	39M	23M
EBT, Incl. Unusual Items	2.22B	15.85B	11B	13.8B	20.39B
Income Tax Expense	847M	4.77B	2.56B	4.46B	5.34B
Earnings From Continuing Operations	1.37B	11.08B	8.44B	9.35B	15.05B
Net Income to Company	1.37B	11.08B	8.44B	9.35B	15.05B
Minority Interest	136M	-528M	-252M	-364M	-592M
Net Income - (IS)	1.5B	10.56B	8.19B	8.99B	14.46B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	1.5B	10.56B	8.19B	8.99B	14.46B
Net Income to Common Excl. Extra Items	1.5B	10.56B	8.19B	8.99B	14.46B
Per Share Items
Net EPS - Basic	10.74	73.42	56.97	62.5	100.56
Basic EPS - Continuing Operations	10.74	73.42	56.97	62.5	100.56
Basic Weighted Average Shares Outstanding	140M	144M	144M	144M	144M
Net EPS - Diluted	10.74	73.42	56.97	62.5	100.56
Diluted EPS - Continuing Operations	10.74	73.42	56.97	62.5	100.56
Diluted Weighted Average Shares Outstanding	140M	144M	144M	144M	144M
Normalized Basic EPS	8.09	51.48	45.5	55.84	81.33
Normalized Diluted EPS	8.09	51.48	45.5	55.84	81.33
Dividend Per Share	3	11.75	15	16	19
Payout Ratio	25.47	4.1	31.16	24	18.89
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	9.75B	20.46B	19.1B	22.12B	27.98B
EBITA	5.67B	15.89B	14.51B	17.07B	22.76B
EBIT	5.67B	15.88B	14.49B	17.07B	22.76B
EBITDAR	10.39B	21.48B	20.54B	23.64B	29.85B
Total Revenues (As Reported)	106B	147B	167B	192B	220B
Effective Tax Rate - (Ratio)	38.24	30.09	23.28	32.27	26.19
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	758M	2.38B	4.06B	4.37B	5.26B
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	89M	2.39B	-1.5B	87M	77M
Normalized Net Income	1.13B	7.4B	6.54B	8.03B	11.69B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	1.38B	1.21B	1.28B	1.5B	1.53B
Non-Cash Pension Expense	17M	15M	19M	36M	45M
Supplemental Operating Expense Items
Marketing Expenses	2B	3.65B	6.4B	6.58B	5.31B
Selling and Marketing Expenses	2B	3.65B	6.4B	6.58B	5.31B
Research And Development Expense From Footnotes	-	-	211M	234M	233M
Net Rental Expense, Total	637M	1.02B	1.43B	1.52B	1.87B
Imputed Operating Lease Interest Expense	423M	656M	856M	889M	958M
Imputed Operating Lease Depreciation	214M	365M	576M	635M	913M
Maintenance & Repair Expenses, Total	1.35B	1.72B	1.94B	1.91B	3.65B
Stock-Based Comp., COGS (Total)	-	-	-	875M	1.13B
Stock-Based Comp., Other (Total)	32M	26M	760M	-	-
Total Stock-Based Compensation	32M	26M	760M	875M	1.13B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.25B	5.83B	4.33B	5.06B	5.78B
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	9.98B	5.01B	2.92B	6.84B	14.32B
Total Cash And Short Term Investments	14.23B	10.84B	7.26B	11.9B	20.1B
Accounts Receivable, Total	14.32B	19.01B	23.82B	26.61B	31.88B
Other Receivables	512M	365M	1.1B	1.46B	1.67B
Notes Receivable	53M	125M	56M	49M	51M
Total Receivables	14.89B	19.5B	24.98B	28.12B	33.61B
Inventory	2.5B	4.32B	3.9B	4.6B	4.81B
Prepaid Expenses	685M	793M	942M	1.06B	1.18B
Other Current Assets, Total	4.11B	5.76B	6.29B	7.12B	10.59B
Total Current Assets	36.41B	41.22B	43.37B	52.8B	70.29B
Gross Property Plant And Equipment	92.54B	105B	118B	137B	155B
Accumulated Depreciation	-27.08B	-32.51B	-37.41B	-42.79B	-48.74B
Net Property Plant And Equipment	65.46B	72.79B	80.34B	93.85B	106B
Long-term Investments	3.45B	2.78B	4.14B	3.42B	11.03B
Goodwill	3.75B	9.24B	9.86B	10.12B	10.3B
Other Intangibles, Total	859M	1.08B	1.06B	1.36B	2.89B
Accounts Receivable Long-Term	5M	5M	5M	4M	5M
Loans Receivable Long-Term	179M	86M	84M	66M	272M
Deferred Tax Assets Long-Term	251M	83M	121M	109M	131M
Other Long-Term Assets, Total	3.8B	4.65B	5.3B	5.8B	5.78B
Total Assets	114B	132B	144B	168B	207B
Liabilities
Accounts Payable, Total	11.6B	16.32B	19.16B	23.69B	22.4B
Accrued Expenses, Total	1.72B	1.68B	2.22B	2.54B	2.85B
Short-term Borrowings	212M	97M	4.42B	6.72B	5.22B
Current Portion of Long-Term Debt	3.65B	1.99B	3.3B	2.55B	3.36B
Current Portion of Leases	704M	991M	1.24B	1.89B	1.75B
Current Income Taxes Payable	5M	30M	28M	13M	16M
Unearned Revenue Current, Total	773M	1.12B	1.34B	1.36B	1.65B
Other Current Liabilities	1.71B	1.61B	1.54B	7.9B	8.53B
Total Current Liabilities	20.38B	23.83B	33.25B	46.64B	45.79B
Long-Term Debt	24.73B	24.27B	19.38B	22.36B	44.17B
Long-Term Leases	12.3B	13.33B	14.98B	19.81B	24.14B
Unearned Revenue Non Current	-	191M	-	-	-
Pension & Other Post Retirement Benefits	223M	233M	553M	732M	623M
Deferred Tax Liability Non Current	2.6B	5.3B	4.42B	4.5B	4.58B
Other Non Current Liabilities	5.9B	5.99B	6.38B	281M	744M
Total Liabilities	66.14B	73.15B	78.96B	94.33B	120B
Common Stock, Total	719M	719M	719M	719M	719M
Additional Paid In Capital	28.64B	28.64B	28.64B	28.64B	28.64B
Retained Earnings	17.18B	27.95B	32.54B	39.11B	50.66B
Comprehensive Income and Other	-511M	-1.07B	83M	884M	2.1B
Total Common Equity	46.02B	56.23B	61.97B	69.35B	82.12B
Minority Interest	2B	2.54B	3.34B	3.85B	4.41B
Total Equity	48.02B	58.78B	65.31B	73.2B	86.53B
Total Liabilities And Equity	114B	132B	144B	168B	207B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	144M	144M	144M	144M	144M
ECS Total Common Shares Outstanding	144M	144M	144M	144M	144M
Book Value / Share	320.1	391.09	431.02	482.35	571.15
Tangible Book Value	41.41B	45.92B	51.06B	57.87B	68.93B
Tangible Book Value Per Share	288.02	319.37	355.09	402.5	479.37
Total Debt	41.6B	40.68B	43.32B	53.33B	78.64B
Net Debt	27.37B	29.84B	36.07B	41.43B	58.54B
Debt Equivalent of Unfunded Proj. Benefit Obligation	537M	453M	630M	790M	861M
Debt Equivalent Oper. Leases	5.1B	8.17B	11.46B	12.19B	14.97B
Minority Interest, Total (Incl. Fin. Div)	2B	2.54B	3.34B	3.85B	4.41B
Equity Method Investments, Total	3.08B	1.99B	1.86B	1.98B	2.24B
Account Code - Inventory Valuation	5	5	5	5	6
Inventories - Raw Materials, Total	164M	153M	117M	173M	675M
Inventories - Finished Goods, Total	1.99B	3.71B	3.14B	3.68B	3.43B
Inventories - Others	341M	452M	639M	740M	703M
Land - (BS)	5.23B	7.98B	8.15B	9.13B	15.45B
Buildings, Total	30.56B	33.54B	34.24B	35.42B	37.06B
Machinery, Total	39.39B	46.22B	49.63B	55.3B	59.48B
Full Time Employees	68.5K	71.11K	83.15K	83.15K	42.5K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	1.68B	1.92B	1.82B	2.17B	2.37B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	1.5B	10.56B	8.19B	8.99B	14.46B
Depreciation & Amortization - CF	5.51B	5.6B	5.75B	6.4B	6.9B
Amortization of Goodwill and Intangible Assets - (CF)	-	7M	14M	-	-
Depreciation & Amortization, Total	5.51B	5.61B	5.76B	6.4B	6.9B
Amortization of Deferred Charges, Total - (CF)	225M	401M	391M	475M	675M
(Gain) Loss From Sale Of Asset	-325M	40M	150M	36M	63M
(Gain) Loss on Sale of Investments - (CF)	-291M	-3.38B	-285M	-393M	-746M
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	432M	-180M	-330M
Stock-Based Compensation (CF)	32M	26M	760M	875M	1.13B
Provision and Write-off of Bad Debts	1.31B	706M	543M	738M	629M
Other Operating Activities, Total	5.49B	6.7B	2.32B	4.2B	4.63B
Change In Accounts Receivable	-5.3B	-3.42B	-5.36B	-3.33B	-5.9B
Change In Inventories	-946M	-1.76B	419M	-692M	-210M
Change In Accounts Payable	2.53B	2.53B	2.81B	4.11B	-1.28B
Change in Other Net Operating Assets	2.99B	-1.73B	-2.36B	-2.01B	1.36B
Cash from Operations	12.73B	16.28B	13.77B	19.2B	21.36B
Capital Expenditure	-2.96B	-6.57B	-11.28B	-11.37B	-17.13B
Sale of Property, Plant, and Equipment	151M	54M	41M	19M	149M
Cash Acquisitions	-	-1B	-499M	-37M	-
Divestitures	5.28B	-	-	-	-
Investment in Marketable and Equity Securities, Total	-11.48B	-733M	2.56B	-4.4B	-17.56B
Net (Increase) Decrease in Loans Originated / Sold - Investing	70M	110M	-18M	24M	-207M
Other Investing Activities, Total	218M	359M	492M	393M	942M
Cash from Investing	-8.72B	-7.78B	-8.71B	-15.37B	-33.81B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	4.77B	4.26B	5.85B	7.07B	25.85B
Total Debt Issued	4.77B	4.26B	5.85B	7.07B	25.85B
Long-Term Debt Repaid, Total	-14.63B	-7.98B	-7.13B	-4.83B	-6.98B
Total Debt Repaid	-14.63B	-7.98B	-7.13B	-4.83B	-6.98B
Issuance of Common Stock	11.7B	-	45M	-	10M
Common Dividends Paid	-383M	-433M	-2.55B	-2.16B	-2.73B
Common & Preferred Stock Dividends Paid	-383M	-433M	-2.55B	-2.16B	-2.73B
Other Financing Activities, Total	-4.86B	-3.77B	-2.54B	-3.2B	-2.98B
Cash from Financing	-3.4B	-7.93B	-6.33B	-3.11B	13.17B
Miscellaneous Cash Flow Adjustments	-165M	1.01B	138M	2M	-
Net Change in Cash	445M	1.58B	-1.13B	721M	726M
Supplemental Items
Cash Interest Paid	4.68B	3.76B	2.51B	3.03B	3.02B
Cash Income Tax Paid (Refund)	-353M	2.04B	3.82B	4.67B	4.86B
Levered Free Cash Flow	5B	4.08B	-245M	11.26B	-6.16B
Unlevered Free Cash Flow	7.54B	6.14B	1.72B	13.46B	-3.52B
Change In Net Working Capital	-1.18B	3.25B	2.97B	-6.42B	9.32B
Net Debt Issued / Repaid	-9.86B	-3.72B	-1.28B	2.25B	18.87B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.12	8.07	6.54	6.84	7.6
Return on Total Capital	3.93	10.5	8.69	9.07	9.75
Return On Equity %	3.31	20.76	13.58	13.5	18.84
Return on Common Equity	3.79	20.65	13.86	13.68	19.09
Margin Analysis
Gross Profit Margin %	29.73	34.99	34.32	34.47	33.72
SG&A Margin	2.5	3.18	4.71	4.25	3.3
EBITDA Margin %	9.24	13.95	11.5	11.6	12.84
EBITA Margin %	5.37	10.84	8.73	8.96	10.44
EBIT Margin %	5.37	10.83	8.72	8.96	10.44
Income From Continuing Operations Margin %	1.3	7.56	5.08	4.91	6.91
Net Income Margin %	1.42	7.2	4.93	4.71	6.63
Net Avail. For Common Margin %	1.42	7.2	4.93	4.71	6.63
Normalized Net Income Margin	1.07	5.05	3.94	4.21	5.37
Levered Free Cash Flow Margin	4.73	2.78	-0.15	5.91	-2.83
Unlevered Free Cash Flow Margin	7.14	4.19	1.03	7.06	-1.61
Asset Turnover
Asset Turnover	0.93	1.19	1.2	1.22	1.17
Fixed Assets Turnover	1.53	2.12	2.17	2.19	2.18
Receivables Turnover (Average Receivables)	8.36	8.8	7.76	7.56	7.45
Inventory Turnover (Average Inventory)	15.03	27.98	26.55	29.39	30.71
Short Term Liquidity
Current Ratio	1.79	1.73	1.3	1.13	1.54
Quick Ratio	1.43	1.27	0.97	0.86	1.17
Operating Cash Flow to Current Liabilities	0.62	0.68	0.41	0.41	0.47
Days Sales Outstanding (Average Receivables)	43.65	41.49	47.02	48.42	48.98
Days Outstanding Inventory (Average Inventory)	24.28	13.05	13.75	12.45	11.88
Average Days Payable Outstanding	54.46	52.45	59.56	62.42	58.15
Cash Conversion Cycle (Average Days)	13.47	2.08	1.2	-1.55	2.71
Long Term Solvency
Total Debt/Equity	86.62	69.21	66.33	72.84	90.89
Total Debt / Total Capital	46.41	40.9	39.88	42.14	47.61
LT Debt/Equity	77.12	63.98	52.61	57.61	78.94
Long-Term Debt / Total Capital	41.32	37.81	31.63	33.33	41.36
Total Liabilities / Total Assets	57.94	55.45	54.73	56.3	58.11
EBIT / Interest Expense	1.4	4.81	4.62	4.84	5.39
EBITDA / Interest Expense	2.75	6.5	6.46	6.66	7.02
(EBITDA - Capex) / Interest Expense	2.03	4.52	2.86	3.43	2.97
Total Debt / EBITDA	3.72	1.89	2.14	2.27	2.65
Net Debt / EBITDA	2.45	1.39	1.78	1.77	1.97
Total Debt / (EBITDA - Capex)	5.06	2.73	4.83	4.41	6.28
Net Debt / (EBITDA - Capex)	3.33	2	4.02	3.42	4.67
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.11	38.85	13.3	14.73	14.35
Gross Profit, 1 Yr. Growth %	-16.66	63.43	11.11	15.9	14.87
EBITDA, 1 Yr. Growth %	-28.47	109.71	-6.6	15.75	26.53
EBITA, 1 Yr. Growth %	-41.63	180.17	-8.72	17.7	33.29
EBIT, 1 Yr. Growth %	-41.6	180.04	-8.76	17.81	33.29
Earnings From Cont. Operations, 1 Yr. Growth %	-68.32	710.23	-23.83	10.74	60.97
Net Income, 1 Yr. Growth %	-66.94	601.86	-22.4	9.71	60.91
Normalized Net Income, 1 Yr. Growth %	-63.49	570.45	-11.71	23.09	45.65
Diluted EPS Before Extra, 1 Yr. Growth %	-67.15	583.57	-22.4	9.71	60.91
Accounts Receivable, 1 Yr. Growth %	30.99	32.69	25.51	11.71	19.82
Inventory, 1 Yr. Growth %	-66.18	73.11	-9.68	17.87	4.57
Net Property, Plant and Equip., 1 Yr. Growth %	-9.85	11.2	10.22	16.82	12.8
Total Assets, 1 Yr. Growth %	0.69	15.55	8.73	16.12	23.3
Tangible Book Value, 1 Yr. Growth %	40.95	10.88	11.59	13.35	19.1
Common Equity, 1 Yr. Growth %	37.84	22.18	10.21	11.91	18.41
Cash From Operations, 1 Yr. Growth %	-1.51	28.73	-18.83	39.46	11.26
Capital Expenditures, 1 Yr. Growth %	-42.4	122.4	71.71	0.74	50.66
Levered Free Cash Flow, 1 Yr. Growth %	38.16	-18.47	-105.07	-4.73K	-156.5
Unlevered Free Cash Flow, 1 Yr. Growth %	15.68	-18.51	-75.12	683.97	-126.13
Dividend Per Share, 1 Yr. Growth %	-50	291.67	27.66	6.67	18.75
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.79	14.18	25.43	14.01	14.54
Gross Profit, 2 Yr. CAGR %	-1.83	16.7	34.75	13.15	13.88
EBITDA, 2 Yr. CAGR %	-3.65	22.48	39.95	3.98	21.02
EBITA, 2 Yr. CAGR %	-8.37	27.88	59.92	3.65	25.25
EBIT, 2 Yr. CAGR %	-8.28	27.88	59.84	3.68	25.31
Earnings From Cont. Operations, 2 Yr. CAGR %	-17.32	60.22	148.43	-8.15	33.52
Net Income, 2 Yr. CAGR %	-20.17	52.33	133.37	-7.74	32.86
Normalized Net Income, 2 Yr. CAGR %	-35.03	54.5	143.41	4.09	33.9
Diluted EPS Before Extra, 2 Yr. CAGR %	-20.43	49.84	130.31	-7.74	32.86
Accounts Receivable, 2 Yr. CAGR %	14.28	31.84	28.95	18.41	15.7
Inventory, 2 Yr. CAGR %	-34.68	-23.49	25.04	3.18	11.02
Net Property, Plant and Equip., 2 Yr. CAGR %	9.94	0.12	10.79	13.47	14.79
Total Assets, 2 Yr. CAGR %	11.5	7.87	12.42	12.36	19.66
Tangible Book Value, 2 Yr. CAGR %	18.44	25.02	11.03	12.47	16.19
Common Equity, 2 Yr. CAGR %	17.5	29.77	16.04	11.06	15.11
Cash From Operations, 2 Yr. CAGR %	18.61	12.21	4.33	6.4	24.56
Capital Expenditures, 2 Yr. CAGR %	-34.03	13.19	95.42	31.52	23.19
Levered Free Cash Flow, 2 Yr. CAGR %	185.82	6.13	-77.86	52.69	403.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	77.74	-2.91	-52.29	39.74	43.14
Dividend Per Share, 2 Yr. CAGR %	-29.29	39.94	123.61	16.69	12.55
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.61	15.09	13.89	21.75	14.12
Gross Profit, 3 Yr. CAGR %	4.95	16.35	14.81	27.9	12.73
EBITDA, 3 Yr. CAGR %	7.48	24.86	11.9	31.37	11.01
EBITA, 3 Yr. CAGR %	8.45	33	14.29	44.39	12.72
EBIT, 3 Yr. CAGR %	8.65	33.06	14.27	44.39	12.73
Earnings From Cont. Operations, 3 Yr. CAGR %	31.94	76.94	25.05	89.78	10.74
Net Income, 3 Yr. CAGR %	8.6	64.76	21.66	81.46	11.06
Normalized Net Income, 3 Yr. CAGR %	-12.68	40.27	28.25	93.73	16.43
Diluted EPS Before Extra, 3 Yr. CAGR %	8.37	62.96	20.33	79.87	11.06
Accounts Receivable, 3 Yr. CAGR %	17.17	20.12	29.63	22.93	18.88
Inventory, 3 Yr. CAGR %	-23.89	-9.61	-19.14	22.6	3.64
Net Property, Plant and Equip., 3 Yr. CAGR %	8.74	10.36	3.43	12.76	13.25
Total Assets, 3 Yr. CAGR %	9.85	12.84	8.36	13.64	15.9
Tangible Book Value, 3 Yr. CAGR %	13.08	15.86	20.22	11.8	14.63
Common Equity, 3 Yr. CAGR %	12.28	19.04	22.89	14.65	13.46
Cash From Operations, 3 Yr. CAGR %	33.35	21.61	2.12	14.94	8
Capital Expenditures, 3 Yr. CAGR %	-21.95	-1.08	30.06	56.69	37.61
Levered Free Cash Flow, 3 Yr. CAGR %	265.37	88.15	-59.23	31.09	8.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	63.55	37.06	-35.9	21.35	-20.09
Dividend Per Share, 3 Yr. CAGR %	-15.66	25.11	35.72	74.72	17.37
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.19	15.11	15.04	14.66	14.15
Gross Profit, 5 Yr. CAGR %	8	16.69	15.98	15.06	14.3
EBITDA, 5 Yr. CAGR %	7.24	23.03	19.45	16.05	15.46
EBITA, 5 Yr. CAGR %	5.46	30.2	26.68	20.38	18.55
EBIT, 5 Yr. CAGR %	5.68	30.49	26.8	20.42	18.56
Earnings From Cont. Operations, 5 Yr. CAGR %	-10.27	53.25	69.95	36.12	28.37
Net Income, 5 Yr. CAGR %	-8.65	36.72	47.48	30.66	26.02
Normalized Net Income, 5 Yr. CAGR %	-9.79	26.18	30.93	24.52	30.4
Diluted EPS Before Extra, 5 Yr. CAGR %	-8.76	35.83	46.51	29.8	25.19
Accounts Receivable, 5 Yr. CAGR %	18.61	20.34	21.75	19.39	23.86
Inventory, 5 Yr. CAGR %	-9.28	-1.54	-7.17	-4.7	-8.21
Net Property, Plant and Equip., 5 Yr. CAGR %	9.25	9.82	9.55	11.62	7.83
Total Assets, 5 Yr. CAGR %	9.18	10.19	10.87	12.78	12.75
Tangible Book Value, 5 Yr. CAGR %	6.81	9.36	12.25	14.41	18.59
Common Equity, 5 Yr. CAGR %	6.68	11.18	13.77	15.78	19.72
Cash From Operations, 5 Yr. CAGR %	16.35	21.2	20.72	16.23	10.57
Capital Expenditures, 5 Yr. CAGR %	-21.88	-0.49	12.68	10.86	27.27
Levered Free Cash Flow, 5 Yr. CAGR %	-5.5	-4.15	19.05	79.05	11.23
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.04	11.21	-0.08	41.36	-11.59
Dividend Per Share, 5 Yr. CAGR %	-12.94	14.39	24.57	21.67	25.93